Arrowhead Research reported $7.88B in Market Capitalization for its fourth fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Agios Pharmaceuticals AGIO:US $ 3B 582.17M
Alnylam Pharmaceuticals ALNY:US $ 15.1B 1.79B
Anika Therapeutics ANIK:US $ 584.51M 58.84M
Arena Pharmaceuticals ARNA:US $ 4.47B 157.33M
Arrowhead Research ARWR:US $ 7.88B 3.48B
Bluebird Bio BLUE:US $ 2.87B 700.76M
Cerulean Pharma CERU:US $ 26.61M 269.13K
Dicerna Pharmaceuticals DRNA:US $ 1.65B 313.72M
Heron Therapeutics HRTX:US $ 1.92B 576.48M
Intercept Pharmaceuticals ICPT:US $ 815.49M 552.38M
Ligand Pharmaceuticals LGND:US $ 1.6B 66.72M
Merk MRK:US $ 206956.82M 2843.73M
Mirati Therapeutics MRTX:US $ 11.04B 3.65B
Moderna Inc MRNA:US $ 41.34B 13.42B
Nektar Therapeutics NKTR:US $ 3.05B 81.83M
Novartis NOVN:VX 206.37B 9.23B
Opko Health OPK:US $ 2.65B 174.82M
Spectrum Pharmaceuticals SPPI:US $ 595.4M 201.74M
Ultragenyx Pharmaceutical RARE:US $ 9.13B 4.15B
Vertex Pharmaceuticals VRTX:US $ 61.46B 9.42B
Xencor XNCR:US $ 2.51B 286.32M
YTE INCY:US $ 19.05B 577.78M